About Cadrenal Therapeutics Inc - Company Information, Overview, History and Profile
What does Cadrenal Therapeutics Inc do?
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.
Cadrenal Therapeutics Inc Board of directors
All Gross Remunerations are in USD